Press "Enter" to skip to content

Analyst nook: Retain ‘reduce’ on Dabur with unchanged FV of Rs 440

Nearly 50% of Dabur’s worldwide enterprise comes from West Asia and Africa.

Even as we anticipate Dabur’s portfolio to be comparatively extra resilient than its friends within the present and post-Covid setting, a few components of the India portfolio might be challenged. GCC publicity may imply some weak spot within the worldwide portfolio as effectively. We issue these features into our mannequin; FY21E/22E EPS forecasts see a 9%/6% minimize. Retain ‘reduce’ in mild of nonetheless punchy valuations; truthful worth (FV) unchanged at Rs 440 per share.

Primary gross sales of all firms have been hit on account of supply-chain disruptions. We are focusing extra on the end-consumption influence. As lengthy as end-consumption demand is undamaged, main gross sales would come again. A great chunk (almost 65%) of Dabur’s India portfolio — haircare, oralcare, homecare and well being dietary supplements — wouldn’t have seen any materials dip in baseline end-consumption. Demand for well being dietary supplements (Chyawanprash, honey, and many others) specifically might have already got elevated or may probably enhance. Other segments (pores and skin, OTC/ moral, digestives & fruit juices) would maybe not be as resilient. Even the resilient segments might be challenged on development on account of a probably slower economic system.

All put collectively, we now estimate a 4% year-on-year development in Dabur’s home enterprise in FY21E, down from round 12% earlier. Nearly 50% of Dabur’s worldwide enterprise comes from West Asia and Africa, the place economies may come beneath important stress on account of weak crude costs and demand. Cross-currency actions add one other layer of unpredictability. We now construct in a 6% drop in Dabur’s worldwide enterprise in FY21E in rupee phrases. For FY22E, we assume development rebounding to 15% ranges.

We have raised our Ebitda margin assumptions regardless of the sharp cuts in income development forecasts. We don’t anticipate a lot SOV stress. Our revised EPS forecasts stand at Rs 10 and Rs 11.three for FY21E and FY22E, respectively. DCF-based truthful worth stands unchanged at Rs 440 per share. ‘Reduce’ stays.

Get reside Stock Prices from BSE and NSE and newest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and comply with us on Twitter.

Financial Express is now on Telegram. Click right here to affix our channel and keep up to date with the most recent Biz information and updates.

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: